These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29645076)

  • 101. Beyond the Knife: The Evolving Nonsurgical Management of Oligometastatic Colorectal Cancer.
    Gill S; Liu DM; Green HM; Sharma RA
    Am Soc Clin Oncol Educ Book; 2018 May; 38():209-219. PubMed ID: 30231355
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Metabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy.
    Klein J; Dawson LA; Tran TH; Adeyi O; Purdie T; Sherman M; Brade A
    Curr Oncol; 2014 Apr; 21(2):e340-4. PubMed ID: 24764717
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma.
    Park J; Park JW; Kang MK
    Yeungnam Univ J Med; 2019 Sep; 36(3):192-200. PubMed ID: 31620633
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Radiation therapy for hepatobiliary malignancies.
    Lischalk JW; Repka MC; Unger K
    J Gastrointest Oncol; 2017 Apr; 8(2):279-292. PubMed ID: 28480067
    [TBL] [Abstract][Full Text] [Related]  

  • 105. How to Improve Therapeutic Ratio in Radiotherapy of HCC.
    Tsai CL; Hsu FM; Cheng JC
    Liver Cancer; 2016 Jul; 5(3):210-20. PubMed ID: 27493896
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Clinical application of advances and innovation in radiation treatment of hepatocellular carcinoma.
    Tong VJW; Shelat VG; Chao YK
    J Clin Transl Res; 2021 Dec; 7(6):811-833. PubMed ID: 34988334
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Ablative radiotherapy for colorectal liver metastases and intrahepatic cholangiocarcinoma.
    Schiff JP; D'Souza A; Henke LE
    Surgery; 2023 Jul; 174(1):108-112. PubMed ID: 36870808
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness.
    Hsu CY; Wang CW; Cheng AL; Kuo SH
    World J Gastrointest Oncol; 2019 Aug; 11(8):579-588. PubMed ID: 31435460
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Cancer and radiation therapy: current advances and future directions.
    Baskar R; Lee KA; Yeo R; Yeoh KW
    Int J Med Sci; 2012; 9(3):193-9. PubMed ID: 22408567
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma.
    Chen CP
    J Clin Transl Hepatol; 2019 Jun; 7(2):183-190. PubMed ID: 31293919
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.
    Willatt J; Hannawa KK; Ruma JA; Frankel TL; Owen D; Barman PM
    World J Hepatol; 2015 Feb; 7(2):235-44. PubMed ID: 25729478
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Proton therapy for hepatocellular carcinoma.
    Ling TC; Kang JI; Bush DA; Slater JD; Yang GY
    Chin J Cancer Res; 2012 Dec; 24(4):361-7. PubMed ID: 23359779
    [TBL] [Abstract][Full Text] [Related]  

  • 113. A 25-year perspective on the evolution of radiation treatment of urologic cancers.
    Hoffman KE; Johnstone P
    Urol Oncol; 2021 Sep; 39(9):577-581. PubMed ID: 34325987
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Featuring the special issue guest editor.
    Lu XJ
    Cancer Lett; 2020 May; 478():70. PubMed ID: 32165271
    [No Abstract]   [Full Text] [Related]  

  • 115. Advances in Radiotherapy for Glioblastoma.
    Mann J; Ramakrishna R; Magge R; Wernicke AG
    Front Neurol; 2017; 8():748. PubMed ID: 29379468
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
    [TBL] [Abstract][Full Text] [Related]  

  • 117. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Kwong AJ; Kim WR; Flemming JA
    Hepatology; 2018 Oct; 68(4):1288-1297. PubMed ID: 29672886
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.
    Wei X; Jiang Y; Zhang X; Feng S; Zhou B; Ye X; Xing H; Xu Y; Shi J; Guo W; Zhou D; Zhang H; Sun H; Huang C; Lu C; Zheng Y; Meng Y; Huang B; Cong W; Lau WY; Cheng S
    J Clin Oncol; 2019 Aug; 37(24):2141-2151. PubMed ID: 31283409
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
    Hara K; Takeda A; Tsurugai Y; Saigusa Y; Sanuki N; Eriguchi T; Maeda S; Tanaka K; Numata K
    Hepatology; 2019 Jun; 69(6):2533-2545. PubMed ID: 30805950
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.